Skip to content

Aptissen SA

Belfort

Grant-only

What changed

Study registered, no phase assigned: 6-month Efficacy and Safety of Synolis VA 80/160 in Hip Osteoarthritis

7mo agoTrial registeredDec 12, 2025Source filing (opens the source filing in a new tab)

Momentum

56no change

Momentum 56 out of 100, unchanged since the last recompute.

Some recent activity, at a steady rate.

Runway (estimate)

unknown

No disclosed raise on file, so there is nothing to model from.

Stage

Grant-only

The furthest-along thing in the public record. Not a projection.

Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.

Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources